How has been the historical performance of Hester Bios?

Answer:The historical performance of Hester Bios shows a steady growth in net sales and profitability over the years, with some fluctuations in specific metrics.

Breakdown:
Hester Bios reported net sales of 311.10 Cr in March 2025, an increase from 304.55 Cr in March 2024 and significantly higher than 266.09 Cr in March 2023. The total operating income followed a similar trend, reaching 311.10 Cr in March 2025. The company's total expenditure, excluding depreciation, was 250.05 Cr in March 2025, slightly down from 250.90 Cr in March 2024, while operating profit (PBDIT) was 64.97 Cr, showing a marginal increase from 64.29 Cr in the previous year. Profit before tax was 35.47 Cr in March 2025, up from 27.34 Cr in March 2024, and profit after tax also increased to 24.73 Cr from 16.56 Cr. The consolidated net profit for March 2025 was 27.49 Cr, compared to 18.89 Cr in March 2024. The company's total assets decreased to 653.38 Cr in March 2025 from 662.35 Cr in March 2024, while total liabilities also fell to 653.38 Cr from 662.35 Cr. Cash flow from operating activities improved to 64.00 Cr in March 2025 from 48.00 Cr in March 2024, although the net cash outflow was -6.00 Cr in March 2025, indicating a decline from the previous year's balance. Overall, Hester Bios has demonstrated resilience and growth in its financial performance, despite some challenges in cash flow and asset management.